Novartis Statistics and Revenue Totals for 2024
Last Updated on: January 14th, 2024
Here are a few of the most interesting Novartis statistics and facts I was able to dig up including restaurant count, revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Novartis Facts
Here is pretty much everything you ever wanted to know about Novartis.
- Website: Official Website
- Year Founded: 1996
- Headquarters: Basel, Switzerland
- Founder(s): Johann Rudolf, Alexander Clavel
- Current Chief Executive: Vasant Narasimhan
- Subsidiaries / Brands: Ciba Vision, Chiron Corp, Sandoz
Novartis International AG, commonly known as Novartis, is a Swiss multinational pharmaceutical and biotechnology company headquartered in Basel, Switzerland. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has grown to become one of the world’s leading pharmaceutical companies, with a strong focus on research, development, and the production of innovative healthcare products.
Novartis operates in several key areas of healthcare, including pharmaceuticals, generics, eye care, and biotechnology. The company develops and markets a wide range of prescription drugs and treatments across various therapeutic areas, including oncology, cardiovascular, neuroscience, immunology, and respiratory.One of Novartis’s subsidiaries, Alcon, specializes in eye care products, such as contact lenses, surgical equipment, and pharmaceuticals for conditions like glaucoma and cataracts. Novartis also has a significant presence in the field of biotechnology, with a focus on developing cutting-edge therapies for complex diseases.
Novartis Statistics
Novartis Revenue Totals
Novartis annual net sales:
- FY 2022: $50.545 billion
- FY 2021: $51.626 billion
- FY 2020: $48.659 billion
- FY 2019: $47.445 billion
- FY 2018: $44.751 billion
- FY 2017: $42.338 billion
- FY 2016: $41.975 billion
- FY 2015: $42.641 billion
Novartis annual net income:
- FY 2022: $6.955 billion
- FY 2021: $24.018 billion
- FY 2020: $8.071 billion
- FY 2019: $11.737 billion
- FY 2018: $12.614 billion
- FY 2017: $7.703 billion
- FY 2016: $6.698 billion
- FY 2015: $17.794 billion
Additional Novartis Statistics
Number of countries where Novartis products are available in:
Last updated 9/25/18
Please note that some of these numbers are easier to find than others. A few of these Novartis statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
